|
A specific immunoprecipitation method for isolating isoforms of insulin-like growth factor binding protein-3 from serum.
|
Bons JA, Michielsen EC, de Boer D, Bouwman FG, Jaeken J, van Dieijen-Visser MP, Rubio-Gozalbo ME, Wodzig WK
|
17904539
|
01-01-2008
|
17-04-2026
|
|
|
Cardiac troponin T release after prolonged strenuous exercise.
|
Michielsen EC, Wodzig WK, Van Dieijen-Visser MP
|
18416595
|
01-01-2008
|
17-04-2026
|
|
|
Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma.
|
Robroeks CM, van de Kant KD, Jöbsis Q, Hendriks HJ, van Gent R, Wouters EF, Damoiseaux JG, Bast A, Wodzig WK, Dompeling E
|
17845410
|
01-09-2007
|
17-04-2026
|
|
|
Clinical proteomics in chronic inflammatory diseases: A review.
|
Bons JA, van Dieijen-Visser MP, Wodzig WK
|
21136762
|
01-09-2007
|
17-04-2026
|
|
|
Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction.
|
Michielsen EC, Diris JH, Kleijnen VW, Wodzig WK, Van Dieijen-Visser MP
|
17512511
|
01-08-2007
|
17-04-2026
|
|
|
Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.
|
Bons JA, Drent M, Bouwman FG, Mariman EC, van Dieijen-Visser MP, Wodzig WK
|
17446058
|
01-08-2007
|
17-04-2026
|
|
|
SGA and measures for muscle mass and strength in surgical Vietnamese patients.
|
Pham NV, Cox-Reijven PL, Wodzig WK, Greve JW, Soeters PB
|
17350806
|
01-04-2007
|
17-04-2026
|
|
|
ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis.
|
Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, van den Bosch JM, Ruven HJ
|
16901684
|
01-03-2007
|
17-04-2026
|
|
|
Size-exclusion chromatography of circulating cardiac troponin T.
|
Michielsen EC, Diris JH, Wodzig WK, Van Dieijen-Visser MP
|
17138853
|
01-12-2006
|
17-04-2026
|
|
|
Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation.
|
Stengl M, Ramakers C, Donker DW, Nabar A, Rybin AV, Spätjens RL, van der Nagel T, Wodzig WK, Sipido KR, Antoons G, Moorman AF, Vos MA, Volders PG
|
16934787
|
01-10-2006
|
17-04-2026
|
|
|
Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry.
|
Bons JA, de Boer D, van Dieijen-Visser MP, Wodzig WK
|
16332361
|
01-04-2006
|
17-04-2026
|
|
|
Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.
|
Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ
|
16549460
|
01-04-2006
|
17-04-2026
|
|
|
Interpretation of cardiac troponin T behaviour in size-exclusion chromatography.
|
Michielsen EC, Diris JH, Kleijnen VW, Wodzig WK, Van Dieijen-Visser MP
|
17163817
|
01-01-2006
|
17-04-2026
|
|
|
Inadequate attempts to measure the microheterogeneity of transthyretin by low-resolution mass spectrometry.
|
de Boer D, Erps MM, Wodzig WK, van Dieijen-Visser MP
|
15976117
|
01-07-2005
|
17-04-2026
|
|
|
Highly sensitive immunoprecipitation method for extracting and concentrating low-abundance proteins from human serum.
|
Michielsen EC, Diris JH, Hackeng CM, Wodzig WK, Van Dieijen-Visser MP
|
15613717
|
01-01-2005
|
17-04-2026
|
|
|
Protein profiling as a diagnostic tool in clinical chemistry: a review.
|
Bons JA, Wodzig WK, van Dieijen-Visser MP
|
16309363
|
01-01-2005
|
17-04-2026
|
|
|
Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood.
|
Bakker J, Gies I, Slavenburg B, Bekers O, Delhaas T, van Dieijen-Visser M
|
15563504
|
01-12-2004
|
25-04-2026
|
|
|
Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
|
Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJ
|
15363639
|
01-10-2004
|
25-04-2026
|
|
|
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder.
|
Wu X, Steet RA, Bohorov O, Bakker J, Newell J, Krieger M, Spaapen L, Kornfeld S, Freeze HH
|
15107842
|
01-05-2004
|
25-04-2026
|
|
|
The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure.
|
van Kimmenade RR, Bakker JA, Crijns HJ, van Dieijen-Visser MP, Pinto YM
|
25696296
|
01-02-2004
|
25-04-2026
|
|
|
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates.
|
de Groot MJ, Wodzig KW, Simoons ML, Glatz JF, Hermens WT
|
10690308
|
01-11-1999
|
17-04-2026
|
|
|
Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.
|
Wodzig KW, Kragten JA, Modrzejewski W, Górski J, van Dieijen-Visser MP, Glatz JF, Hermens WT
|
9641361
|
27-04-1998
|
17-04-2026
|
|
|
One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein.
|
Wodzig KW, Pelsers MM, van der Vusse GJ, Roos W, Glatz JF
|
9158823
|
01-05-1997
|
17-04-2026
|
|
|
Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function.
|
Wodzig KW, Kragten JA, Hermens WT, Glatz JF, van Dieijen-Visser MP
|
9127740
|
01-03-1997
|
17-04-2026
|
|
|
Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein.
|
Van Nieuwenhoven FA, Kleine AH, Wodzig WH, Hermens WT, Kragten HA, Maessen JG, Punt CD, Van Dieijen MP, Van der Vusse GJ, Glatz JF
|
7586251
|
15-11-1995
|
17-04-2026
|
|
